Display Settings:

Format

Send to:

Choose Destination

    Curr Opin Investig Drugs. 2002 Sep;3(9):1334-41.

    Pitavastatin Nissan/Kowa Yakuhin/Novartis/Sankyo.

    Flores NA.

    University College London, Institute of Urology and Nephrology, Division of Applied Physiology, 48 Riding House Street, London, W1W 7EY, UK. naflor40@hotmail.com

    Pitavastatin (nisvastatin) is an HMG CoA reductase inhibitor being developed jointly by Nissan, Kowa Kogyo, Novartis and Sankyo for the potential treatment of atherosclerosis and hyperlipidemia.

    PMID: 12498010 [PubMed - indexed for MEDLINE]

    Supplemental Content